“Smart investors will look for biotech stocks that have drug pipelines full of good prospects, as well as balance sheets strong enough to withstand any unforeseen problems,” acknowledges the author of today’s article before proceeding to highlight seven biotech stocks that fit this bill. For these seven stocks that may be among the best biotech picks – from a “multibillion-dollar biotech behemoth provid[ing] investors with exposure to treatments for a wide range of ailments” to a mid-cap biotech with a singular focus on curing sickle cell disease – CLICK HERE.